Literature DB >> 33864093

Turning strength into weakness: protein degradation and autophagy as therapeutic targets in glioblastoma?

Simone P Niclou1,2, Anna Golebiewska1.   

Abstract

Entities:  

Mesh:

Year:  2021        PMID: 33864093      PMCID: PMC8263154          DOI: 10.1093/neuonc/noab099

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  7 in total

1.  A Patient-Derived Cell Atlas Informs Precision Targeting of Glioblastoma.

Authors:  Patrik Johansson; Cecilia Krona; Soumi Kundu; Milena Doroszko; Sathishkumar Baskaran; Linnéa Schmidt; Claire Vinel; Elin Almstedt; Ramy Elgendy; Ludmila Elfineh; Caroline Gallant; Sara Lundsten; Fernando J Ferrer Gago; Aleksi Hakkarainen; Petra Sipilä; Maria Häggblad; Ulf Martens; Bo Lundgren; Melanie M Frigault; David P Lane; Fredrik J Swartling; Lene Uhrbom; Marika Nestor; Silvia Marino; Sven Nelander
Journal:  Cell Rep       Date:  2020-07-14       Impact factor: 9.423

Review 2.  Exploring the proteasome system: A novel concept of proteasome inhibition and regulation.

Authors:  Xinyuan Wang; Thomas Meul; Silke Meiners
Journal:  Pharmacol Ther       Date:  2020-03-13       Impact factor: 12.310

3.  PTEN deficiency leads to proteasome addiction: a novel vulnerability in glioblastoma.

Authors:  Jorge A Benitez; Darren Finlay; Anthony Castanza; Alison D Parisian; Jianhui Ma; Ciro Longobardi; Alex Campos; Raghavendra Vadla; Alejandro Izurieta; Gianluca Scerra; Tomoyuki Koga; Tao Long; Lukas Chavez; Jill P Mesirov; Kristiina Vuori; Frank Furnari
Journal:  Neuro Oncol       Date:  2021-07-01       Impact factor: 13.029

4.  Regulation of hypoxia-induced autophagy in glioblastoma involves ATG9A.

Authors:  Siti Aminah Abdul Rahim; Anne Dirkse; Anais Oudin; Anne Schuster; Jill Bohler; Vanessa Barthelemy; Arnaud Muller; Laurent Vallar; Bassam Janji; Anna Golebiewska; Simone P Niclou
Journal:  Br J Cancer       Date:  2017-08-10       Impact factor: 7.640

Review 5.  Targeting PI3K in cancer: mechanisms and advances in clinical trials.

Authors:  Jing Yang; Ji Nie; Xuelei Ma; Yuquan Wei; Yong Peng; Xiawei Wei
Journal:  Mol Cancer       Date:  2019-02-19       Impact factor: 27.401

Review 6.  A Practical Review of Proteasome Pharmacology.

Authors:  Tiffany A Thibaudeau; David M Smith
Journal:  Pharmacol Rev       Date:  2019-04       Impact factor: 25.468

Review 7.  Proteasome inhibition for the treatment of glioblastoma.

Authors:  Patrick Roth; Warren P Mason; Paul G Richardson; Michael Weller
Journal:  Expert Opin Investig Drugs       Date:  2020-08-10       Impact factor: 6.206

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.